NASDAQ: SBRA · Healthcare Facility REITs
Sabra Health Care REIT (SBRA) fair value: undervalued or overvalued?
As of 3 Oct 2026, Faircurve's model values Sabra Health Care REIT (SBRA) at $16.04 a share. The stock last closed at $19.16, which puts the model's fair value 16.3% below the price. On the model's bands that reads as Overvalued.
Revalued . Price is the close of 2 Oct 2026. Sabra Health Care REIT, Inc.
Faircurve Insights · 3 Oct 2026
Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company is headquartered in Tustin, CA.
Faircurve's model found a fair value of $16.04 a share on 3 Oct 2026. The fair value moved -1.8% since the previous run on 26 Sep 2026, which gave $16.33. The calibrated range over 63 trading days is $13.38 to $19.45, and ranges built this way held the price 60% of the time at this horizon. The model's evidence grade is High.
The model compares Sabra Health Care REIT, Inc. with Healthcare Realty Trust Incorporated, CareTrust REIT, Inc., LTC Properties, Inc., Medical Properties Trust, Inc., Healthpeak Properties, Inc., Omega Healthcare Investors, Inc., and Ventas, Inc. The stock's median move around its last 8 earnings reports, ignoring direction, was 3.4%.
Written from the figures on this page for the 3 Oct 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
What price range does the model give SBRA?
The calibrated range for SBRA over 63 trading days is $13.38 to $19.45. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 4,809 past valuations, refreshed 3 Oct 2026). Ranges built this way held the price 60% of the time at this horizon.
The model's own range is $14.89 to $17.32.
How does SBRA compare with similar companies?
The companies in healthcare facility reits closest to Sabra Health Care REIT in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| HR Healthcare Realty Trust Incorporated | $17.47 | $15.70 | -10.1% | Overvalued |
| CTRE CareTrust REIT, Inc. | $36.30 | $31.30 | -13.8% | Overvalued |
| AHR American Healthcare REIT, Inc. | $50.75 | $22.78 | -55.1% | Low evidence grade |
| LTC LTC Properties, Inc. | $43.00 | $42.49 | -1.2% | Fairly valued |
| MPT Medical Properties Trust, Inc. | $3.27 | $4.49 | +37.3% | Undervalued |
| DOC Healthpeak Properties, Inc. | $19.49 | $23.77 | +22.0% | Undervalued |
| OHI Omega Healthcare Investors, Inc. | $45.72 | $52.53 | +14.9% | Undervalued |
| VTR Ventas, Inc. | $84.01 | $42.41 | -49.5% | Overvalued |
All healthcare facility reit stocks ranked by gap to fair value
When does SBRA report earnings, and how has the stock reacted?
Sabra Health Care REIT's next earnings report is scheduled for 4 Nov 2026. Companies can move their dates.
How SBRA moved around its last 8 earnings reports
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across these 8 reports, ignoring direction, was 3.4%.
| Report date | Two session move |
|---|---|
| 3 Aug 2026 | -2.4% |
| 29 Apr 2026 | +0.7% |
| 12 Feb 2026 | +2.9% |
| 5 Nov 2025 | +4.8% |
| 4 Aug 2025 | -0.6% |
| 5 May 2025 | +9.8% |
| 20 Feb 2025 | -4.0% |
| 31 Oct 2024 | -4.8% |
Sabra Health Care REIT at a glance
Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
- Market value
- $4.8B
- Sector
- Real Estate
- Industry
- Healthcare Facility REITs
- Beta to the US market
- -0.25
- First valued by Faircurve
- 11 Jul 2026
How the fair value is worked out: the model values Sabra Health Care REIT three ways and blends them; the range around the fair value comes from 2,000 simulations of the dividend model. The full method is documented here.
What changed in the latest valuation?
On 26 Sep 2026 the model's fair value for SBRA was $16.33. As of 3 Oct 2026 it is $16.04, a change of -1.8%. The model revalues every stock it covers each week, and again after an earnings report.
Questions about Sabra Health Care REIT's valuation
Is Sabra Health Care REIT stock undervalued or overvalued?
On Faircurve's model, SBRA reads as Overvalued as of 3 Oct 2026. The model's fair value is $16.04 a share against a last close of $19.16, a gap of -16.3%.
What is SBRA's fair value?
$16.04 a share as of 3 Oct 2026. The fair value blends three methods: a cash-flow multiple against comparable companies, a dividend model, and the value of the properties. The model's own range is $14.89 to $17.32.
What price range does the model give SBRA?
$13.38 to $19.45 over 63 trading days. Ranges built this way held the price 60% of the time across 4,809 past valuations, refreshed 3 Oct 2026.
When does Sabra Health Care REIT report earnings next?
The next report is scheduled for 4 Nov 2026. Companies can move their dates.
How much has SBRA moved on past earnings reports?
Across its last 8 reports the median two session move was 3.4%, ignoring direction. The largest was +9.8% around the report of 5 May 2025.
How confident is the model in this valuation?
The model's evidence grade for SBRA is high. For real estate investment trusts (REITs) the grade looks at the dividend record: at least three years of paid dividends with no cut. It is not a probability that the fair value is right, or that the price reaches it.